Home - Products - Others - Other Targets - 2,3-Dihydro-3-hydroxy-2-oxo-1H-indole-3-acetic acid

2,3-Dihydro-3-hydroxy-2-oxo-1H-indole-3-acetic acid

CAS No. 57061-17-3

2,3-Dihydro-3-hydroxy-2-oxo-1H-indole-3-acetic acid( ——— )

Catalog No. M39597 CAS No. 57061-17-3

2-(3-Hydroxy-2-oxoindolin-3-yl)-acetic acid (compound 29) is a natural polyphenol compound found in hop bract.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 357 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    2,3-Dihydro-3-hydroxy-2-oxo-1H-indole-3-acetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    2-(3-Hydroxy-2-oxoindolin-3-yl)-acetic acid (compound 29) is a natural polyphenol compound found in hop bract.
  • Description
    2-(3-Hydroxy-2-oxoindolin-3-yl)-acetic acid (compound 29) is a natural polyphenol compound found in hop bract.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    57061-17-3
  • Formula Weight
    207.18
  • Molecular Formula
    C10H9NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yoshihisa Tanaka, et al. Comprehensive separation and structural analyses of polyphenols and related compounds from bracts of hops (Humulus lupulus L.). J Agric Food Chem. 2014 Mar 12;62(10):2198-206. ?
molnova catalog
related products
  • Sarmenoside III

    Sarmenoside III is a flavonol glycoside with hepatoprotective activity isolated from Sedum sarmentosum.

  • AZ876

    AZ876 is a potent highly selective LXR agonist with Ki/EC50 of 7/6 nM and 11/73 nM for hLXRα and hLXRβ respectively.

  • BV02

    BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.